Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sugih Energy Tbk. (SUGI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Sugih Energy Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Sugih Energy Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Sugih Energy Tbk. trades at Rp50 (market cap 1.24T), while Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 10× Sugih Energy Tbk.'s market cap. Which is the better fit depends on your goals.

SUGITSPC
Market Cap
1.24T12.36T
Volume
1.41M
Lot
14.08K
Turnover
3.83B
Average Price
2,722.04
Value
3.83B
Indicative Equilibrium Price
2,730
Indicative Equilibrium Volume
2.51K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

TSPC
View details

About Sugih Energy Tbk.

PT Sugih Energy Tbk was established based on Notarial Deed No. 90, in Jakarta as PT. Saranatama Unimada Gunabina International on March 26th 1990. On 1992, corporate began the operation as sole agent of diesel generator leasing company, Aggreko Benerator, Plc., Australia. On 1997, corporate elected as Daewoo heavy equipments sole agent, but caused of monetary & political crisis in Indonesia, corporate return the agency. On 2000, corporate develope the automotive spare parts distributor business, that was handled by PT. Prima Samapersada (afiliated) which conducted in this business since 1982. On 2001, corporate continued the agency of HINO Truck from PT. Indo Samapersada (afiliated) untill now.

Read more on SUGI

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC